Biotechnology
The Biotechnology industry has a total of 596 stocks, with a combined market cap of $1.32 trillion and total revenue of $123.1 billion.
Market Cap
1.32T
Revenue
123.1B
Profits
-32.45B
PE Ratio
n/a
Profit Margin
-26.36%
Dividend Yield
0.04%
596 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 138.71B | 0.85% | 1,271,668 | 12.95B |
| 2 | MRNA | Moderna, Inc. | 102.85B | 5.27% | 16,329,245 | 2.53B |
| 3 | REGN | Regeneron Pharmaceuticals, Inc. | 90.75B | 0.16% | 1,122,908 | 16.90B |
| 4 | ARGX | argenx SE | 56.88B | 3.63% | 379,268 | 5.92B |
| 5 | ONC | BeOne Medicines AG | 46.49B | 5.09% | 941,743 | 6.61B |
| 6 | RVMD | Revolution Medicines, Inc. | 41.59B | 8.24% | 4,497,777 | 197.56M |
| 7 | RPRX | Royalty Pharma plc | 38.60B | -0.40% | 4,836,501 | 2.62B |
| 8 | GMAB | Genmab A/S | 33.29B | 1.69% | 7,828,333 | 4.30B |
| 9 | ROIV | Roivant Sciences Ltd. | 28.08B | 6.17% | 12,265,362 | 7.53M |
| 10 | INSM | Insmed Incorporated | 25.10B | 5.19% | 3,379,993 | 1.52B |
| 11 | INCY | Incyte Corporation | 24.39B | 1.39% | 1,486,495 | 6.01B |
| 12 | BNTX | BioNTech SE | 21.70B | 1.92% | 724,190 | 2.75B |
| 13 | ALNY | Alnylam Pharmaceuticals, Inc. | 20.89B | -0.46% | 2,829,904 | 5.01B |
| 14 | EXEL | Exelixis, Inc. | 16.98B | 1.25% | 2,003,609 | 2.50B |
| 15 | ASND | Ascendis Pharma A/S | 16.87B | 1.33% | 883,846 | 1.20B |
| 16 | JAZZ | Jazz Pharmaceuticals plc | 15.07B | 3.27% | 887,563 | 4.72B |
| 17 | BBIO | BridgeBio Pharma, Inc. | 14.47B | 0.03% | 3,157,601 | 945.54M |
| 18 | SMMT | Summit Therapeutics Inc. | 13.06B | 15.08% | 5,795,790 | - |
| 19 | HALO | Halozyme Therapeutics, Inc. | 11.81B | -15.72% | 6,163,118 | 1.80B |
| 20 | TECH | Bio-Techne Corporation | 11.43B | 0.17% | 2,307,628 | 1.23B |
| 21 | KYMR | Kymera Therapeutics, Inc. | 11.25B | 2.82% | 786,959 | 102.24M |
| 22 | BMRN | BioMarin Pharmaceutical Inc. | 10.85B | -0.16% | 2,733,264 | 3.66B |
| 23 | PCVX | Vaxcyte, Inc. | 10.11B | 3.18% | 1,841,189 | - |
| 24 | SYRE | Spyre Therapeutics, Inc. | 9.86B | 7.53% | 1,635,370 | - |
| 25 | MDGL | Madrigal Pharmaceuticals, Inc. | 9.28B | -0.12% | 1,088,724 | 1.43B |
| 26 | IBRX | ImmunityBio, Inc. | 9.15B | 7.80% | 9,274,185 | 165.79M |
| 27 | KRYS | Krystal Biotech, Inc. | 8.92B | 0.21% | 234,214 | 470.03M |
| 28 | PTGX | Protagonist Therapeutics, Inc. | 8.54B | -2.38% | 972,945 | 551.69M |
| 29 | TGTX | TG Therapeutics, Inc. | 8.49B | 3.18% | 2,305,800 | 799.54M |
| 30 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.22B | 1.22% | 1,363,197 | 669.50M |
| 31 | CORT | Corcept Therapeutics Incorporated | 7.96B | 1.59% | 1,406,677 | 963.65M |
| 32 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.78B | 6.91% | 4,935,695 | 280.75M |
| 33 | PRAX | Praxis Precision Medicines, Inc. | 7.75B | 5.72% | 320,915 | 7.46M |
| 34 | TWST | Twist Bioscience Corporation | 7.57B | 0.15% | 2,055,315 | 431.80M |
| 35 | ABVX | ABIVAX Société Anonyme | 7.50B | 1.84% | 827,192 | 5.33M |
| 36 | CYTK | Cytokinetics, Incorporated | 7.48B | -3.35% | 2,562,876 | 113.29M |
| 37 | CAI | Caris Life Sciences, Inc. | 7.24B | -3.07% | 10,289,412 | 1.05B |
| 38 | AXSM | Axsome Therapeutics, Inc. | 6.96B | 1.98% | 718,397 | 865.27M |
| 39 | ORKA | Oruka Therapeutics, Inc. | 6.81B | 7.12% | 1,071,383 | - |
| 40 | CGON | CG Oncology, Inc. | 6.74B | 17.27% | 3,661,960 | 6.17M |
| 41 | IONS | Ionis Pharmaceuticals, Inc. | 6.55B | 1.60% | 2,911,837 | 874.09M |
| 42 | IMVT | Immunovant, Inc. | 6.31B | 7.54% | 2,658,533 | - |
| 43 | KOD | Kodiak Sciences Inc. | 6.23B | 9.10% | 1,054,625 | - |
| 44 | BLTE | Belite Bio, Inc | 6.21B | 7.68% | 174,529 | - |
| 45 | LGND | Ligand Pharmaceuticals Incorporated | 6.12B | 2.41% | 133,030 | 253.83M |
| 46 | MIRM | Mirum Pharmaceuticals, Inc. | 6.12B | 0.19% | 722,721 | 670.78M |
| 47 | MANE | Veradermics, Incorporated | 5.80B | 7.92% | 503,271 | - |
| 48 | SRRK | Scholar Rock Holding Corporation | 5.72B | 3.16% | 2,096,407 | - |
| 49 | COGT | Cogent Biosciences, Inc. | 5.49B | 6.98% | 1,481,763 | - |
| 50 | PTCT | PTC Therapeutics, Inc. | 5.47B | -0.35% | 898,968 | 1.16B |
| 51 | ERAS | Erasca, Inc. | 5.04B | 8.59% | 4,032,150 | - |
| 52 | EWTX | Edgewise Therapeutics, Inc. | 4.93B | 15.87% | 3,716,881 | - |
| 53 | CRSP | CRISPR Therapeutics AG | 4.86B | 3.11% | 1,235,249 | 25.17M |
| 54 | DNTH | Dianthus Therapeutics, Inc. | 4.84B | 3.64% | 595,296 | 2.72M |
| 55 | TVTX | Travere Therapeutics, Inc. | 4.76B | 1.49% | 1,012,203 | 651.03M |
| 56 | LEGN | Legend Biotech Corporation | 4.53B | 3.82% | 1,767,092 | 1.27B |
| 57 | DFTX | Definium Therapeutics, Inc. | 4.47B | 9.58% | 1,278,327 | - |
| 58 | RLAY | Relay Therapeutics, Inc. | 4.11B | 9.41% | 3,200,741 | 10.35M |
| 59 | ABCL | AbCellera Biologics Inc. | 3.85B | 6.74% | 2,210,673 | 66.17M |
| 60 | XENE | Xenon Pharmaceuticals Inc. | 3.79B | 3.95% | 869,646 | 7.50M |
| 61 | IOVA | Iovance Biotherapeutics, Inc. | 3.72B | 3.88% | 12,955,715 | 378.98M |
| 62 | ACAD | Acadia Pharmaceuticals Inc. | 3.67B | -0.05% | 1,770,851 | 1.20B |
| 63 | TNGX | Tango Therapeutics, Inc. | 3.63B | 3.02% | 2,129,303 | 53.81M |
| 64 | ELVN | Enliven Therapeutics, Inc. | 3.62B | 10.36% | 969,794 | - |
| 65 | PBLS | Parabilis Medicines, Inc. | 3.52B | 2.33% | 629,325 | 148.00K |
| 66 | IRON | Disc Medicine, Inc. | 3.50B | 0.56% | 717,551 | - |
| 67 | VKTX | Viking Therapeutics, Inc. | 3.42B | 4.07% | 2,668,175 | - |
| 68 | TARS | Tarsus Pharmaceuticals, Inc. | 3.38B | 1.60% | 1,090,209 | 682.20M |
| 69 | DYN | Dyne Therapeutics, Inc. | 3.37B | 4.09% | 2,359,189 | - |
| 70 | CELC | Celcuity Inc. | 3.27B | 4.29% | 1,081,681 | - |
| 71 | VRDN | Viridian Therapeutics, Inc. | 3.24B | -0.21% | 4,501,358 | 26.31M |
| 72 | ARQT | Arcutis Biotherapeutics, Inc. | 3.23B | -5.37% | 3,262,351 | 508.68M |
| 73 | DNLI | Denali Therapeutics Inc. | 3.22B | 1.77% | 1,586,648 | 21.38M |
| 74 | TLX | Telix Pharmaceuticals Limited | 3.19B | 2.23% | 311,773 | 890.79M |
| 75 | ZLAB | Zai Lab Limited | 3.16B | 12.74% | 1,894,887 | 441.73M |
| 76 | IDYA | IDEAYA Biosciences, Inc. | 3.02B | 1.92% | 1,652,527 | 36.54M |
| 77 | ADMA | ADMA Biologics, Inc. | 2.82B | -3.63% | 4,647,813 | 519.15M |
| 78 | VCEL | Vericel Corporation | 2.79B | 5.48% | 1,616,567 | 324.17M |
| 79 | XNCR | Xencor, Inc. | 2.68B | 4.99% | 1,116,055 | 200.49M |
| 80 | BEAM | Beam Therapeutics Inc. | 2.63B | 2.09% | 1,984,920 | 146.64M |
| 81 | RCUS | Arcus Biosciences, Inc. | 2.63B | 3.34% | 1,055,363 | 100.00M |
| 82 | PVLA | Palvella Therapeutics, Inc. | 2.53B | 12.16% | 502,032 | - |
| 83 | MBX | MBX Biosciences, Inc. | 2.47B | 5.96% | 488,160 | - |
| 84 | PHVS | Pharvaris N.V. | 2.41B | 5.72% | 405,107 | - |
| 85 | CLDX | Celldex Therapeutics, Inc. | 2.35B | 5.66% | 926,320 | 158.00K |
| 86 | COAG | Hemab Therapeutics Holdings, Inc. | 2.29B | 7.57% | 427,951 | - |
| 87 | SEPN | Septerna, Inc. | 2.28B | 3.17% | 384,550 | 98.88M |
| 88 | NAMS | NewAmsterdam Pharma Company N.V. | 2.27B | 0.05% | 1,706,198 | 25.94M |
| 89 | IMNM | Immunome, Inc. | 2.21B | 4.47% | 1,333,752 | 4.02M |
| 90 | AUPH | Aurinia Pharmaceuticals Inc. | 2.21B | 1.54% | 1,275,137 | 321.74M |
| 91 | RXRX | Recursion Pharmaceuticals, Inc. | 2.19B | 0.57% | 15,585,949 | 68.23M |
| 92 | BHVN | Biohaven Ltd. | 2.19B | 4.17% | 2,921,603 | - |
| 93 | VERA | Vera Therapeutics, Inc. | 2.15B | -1.18% | 2,078,214 | 10.28M |
| 94 | FTRE | Fortrea Holdings Inc. | 2.12B | 7.33% | 1,941,806 | 2.67B |
| 95 | LKFT | Lakefront Biotherapeutics NV | 2.11B | -0.33% | 374,143 | 1.13B |
| 96 | ZYME | Zymeworks Inc. | 2.10B | 3.10% | 907,970 | 37.13M |
| 97 | VIR | Vir Biotechnology, Inc. | 2.09B | 10.80% | 1,896,933 | 302.80M |
| 98 | REPL | Replimune Group, Inc. | 2.05B | 7.99% | 2,975,062 | - |
| 99 | TRVI | Trevi Therapeutics, Inc. | 2.04B | 11.87% | 2,549,175 | - |
| 100 | TRAX | First Tracks Biotherapeutics, Inc. | 2.01B | 5.44% | 590,296 | - |
| 101 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.95B | 7.74% | 1,936,351 | 213.00M |
| 102 | HRMY | Harmony Biosciences Holdings, Inc. | 1.94B | 1.97% | 787,173 | 989.36M |
| 103 | ZBIO | Zenas BioPharma, Inc. | 1.92B | 8.99% | 543,968 | 11.00M |
| 104 | SRPT | Sarepta Therapeutics, Inc. | 1.91B | 1.42% | 2,596,795 | 1.96B |
| 105 | MAZE | Maze Therapeutics, Inc. | 1.84B | 5.10% | 563,891 | 20.00M |
| 106 | MESO | Mesoblast Limited | 1.81B | 1.21% | 192,844 | 120.25M |
| 107 | NVAX | Novavax, Inc. | 1.78B | 10.22% | 6,292,904 | 411.65M |
| 108 | LYCA | Lycia Therapeutics, Inc. | 1.76B | 5.90% | 370,060 | 4.44M |
| 109 | AGIO | Agios Pharmaceuticals, Inc. | 1.76B | 4.03% | 1,281,178 | 140.84M |
| 110 | ABSI | Absci Corporation | 1.75B | 8.31% | 4,161,242 | 1.56M |
| 111 | STOK | Stoke Therapeutics, Inc. | 1.74B | 1.80% | 1,162,631 | 28.21M |
| 112 | SLS | SELLAS Life Sciences Group, Inc. | 1.70B | 6.85% | 7,623,254 | - |
| 113 | KLRA | Kailera Therapeutics, Inc. | 1.68B | 6.57% | 733,264 | - |
| 114 | GENB | Generate Biomedicines, Inc. | 1.68B | 3.90% | 632,195 | 26.48M |
| 115 | NRIX | Nurix Therapeutics, Inc. | 1.67B | 3.10% | 2,975,687 | 701.94M |
| 116 | PGEN | Precigen, Inc. | 1.60B | 5.92% | 9,238,231 | 156.94M |
| 117 | IMCR | Immunocore Holdings plc | 1.60B | 9.12% | 1,526,531 | 429.30M |
| 118 | NTLA | Intellia Therapeutics, Inc. | 1.59B | 2.25% | 4,404,708 | 52.89M |
| 119 | RARE | Ultragenyx Pharmaceutical Inc. | 1.57B | -0.90% | 4,049,187 | 730.00M |
| 120 | NBTX | Nanobiotix S.A. | 1.53B | 2.03% | 136,240 | 13.15M |
| 121 | QURE | uniQure N.V. | 1.52B | 3.28% | 1,172,907 | 20.17M |
| 122 | BRVE | Braveheart Bio, Inc. | 1.52B | 6.77% | 702,051 | - |
| 123 | ADRX | ADARx Pharmaceuticals, Inc. | 1.48B | -0.45% | 440,017 | 6.13M |
| 124 | NUVB | Nuvation Bio Inc. | 1.47B | -0.72% | 5,335,950 | 201.73M |
| 125 | DMRA | Damora Therapeutics, Inc. | 1.47B | 8.42% | 360,453 | - |
| 126 | TYRA | Tyra Biosciences, Inc. | 1.45B | 1.24% | 862,266 | - |
| 127 | KARD | Kardigan, Inc. | 1.45B | 11.98% | 406,631 | - |
| 128 | GPCR | Structure Therapeutics Inc. | 1.45B | 6.66% | 1,621,152 | - |
| 129 | RAPP | Rapport Therapeutics, Inc. | 1.45B | 3.04% | 866,476 | 20.00M |
| 130 | OCUL | Ocular Therapeutix, Inc. | 1.45B | 2.57% | 1,957,239 | 52.06M |
| 131 | KRSA | Korsana Biosciences, Inc. | 1.41B | 2.04% | 65,601 | - |
| 132 | TSHA | Taysha Gene Therapies, Inc. | 1.41B | 5.87% | 3,182,537 | 5.49M |
| 133 | ANAB | AnaptysBio, Inc. | 1.39B | 1.91% | 287,785 | 106.09M |
| 134 | AAPG | Ascentage Pharma Group International | 1.37B | 1.98% | 5,544 | 94.61M |
| 135 | INVA | Innoviva, Inc. | 1.36B | -0.73% | 1,654,268 | 438.32M |
| 136 | MLYS | Mineralys Therapeutics, Inc. | 1.36B | 0.59% | 1,335,400 | - |
| 137 | LBRX | LB Pharmaceuticals Inc | 1.36B | 10.29% | 480,310 | - |
| 138 | AVLN | Avalyn Pharma Inc. | 1.29B | 9.30% | 630,263 | - |
| 139 | GHRS | GH Research PLC | 1.28B | 0.92% | 453,631 | - |
| 140 | NKTR | Nektar Therapeutics | 1.27B | 3.07% | 686,445 | 54.59M |
| 141 | DRTS | Alpha Tau Medical Ltd. | 1.27B | 3.16% | 418,041 | - |
| 142 | MNKD | MannKind Corporation | 1.25B | 3.72% | 4,985,292 | 413.37M |
| 143 | INBX | Inhibrx Biosciences, Inc. | 1.24B | 5.28% | 220,248 | 1.30M |
| 144 | SGP | SpyGlass Pharma, Inc. | 1.24B | 8.41% | 109,376 | - |
| 145 | SVRA | Savara Inc. | 1.23B | 10.27% | 2,226,928 | - |
| 146 | OMER | Omeros Corporation | 1.22B | -0.88% | 1,016,466 | 38.42M |
| 147 | VOR | Vor Biopharma Inc. | 1.22B | 6.54% | 555,463 | - |
| 148 | URGN | UroGen Pharma Ltd. | 1.21B | -3.81% | 1,761,232 | 250.25M |
| 149 | SLN | Silence Therapeutics plc | 1.19B | 0.05% | 958,443 | 615.00K |
| 150 | SPTX | Seaport Therapeutics, Inc. | 1.15B | 5.44% | 227,030 | - |
| 151 | JANX | Janux Therapeutics, Inc. | 1.08B | 9.78% | 852,278 | 23.29M |
| 152 | VSTM | Verastem, Inc. | 1.06B | -10.34% | 7,038,351 | 100.30M |
| 153 | ANRO | Alto Neuroscience, Inc. | 987.33M | 15.04% | 617,535 | - |
| 154 | MLTX | MoonLake Immunotherapeutics | 981.28M | 6.76% | 1,033,955 | - |
| 155 | JBIO | Jade Biosciences, Inc. | 958.41M | 6.88% | 596,541 | - |
| 156 | ODTX | Odyssey Therapeutics, Inc. | 921.91M | 1.85% | 577,256 | 99.00K |
| 157 | ORIC | ORIC Pharmaceuticals, Inc. | 914.22M | 3.89% | 556,747 | - |
| 158 | CTY | City Therapeutics, Inc. | 908.06M | 6.91% | 311,821 | 14.34M |
| 159 | GLUE | Monte Rosa Therapeutics, Inc. | 903.21M | 3.12% | 1,005,563 | 70.33M |
| 160 | IVA | Inventiva S.A. | 895.70M | 4.68% | 2,220,601 | 2.81M |
| 161 | CRVS | Corvus Pharmaceuticals, Inc. | 886.63M | 8.32% | 1,257,480 | - |
| 162 | AKTS | Aktis Oncology, Inc. | 879.90M | 6.53% | 362,862 | 10.06M |
| 163 | IMTX | Immatics N.V. | 869.35M | 2.91% | 1,063,382 | 47.65M |
| 164 | PHAR | Pharming Group N.V. | 869.24M | -0.08% | 9,729 | 386.75M |
| 165 | MGTX | MeiraGTx Holdings plc | 864.39M | 5.76% | 703,329 | 397.50M |
| 166 | SNDX | Syndax Pharmaceuticals, Inc. | 858.87M | 1.81% | 4,171,071 | 289.68M |
| 167 | OBX | Obsidian Therapeutics, Inc. | 856.48M | 44.43% | 2,092,191 | - |
| 168 | LTGO | Latigo Biotherapeutics, Inc. | 835.37M | -3.15% | 556,053 | - |
| 169 | PRME | Prime Medicine, Inc. | 827.26M | 4.49% | 3,059,122 | 4.07M |
| 170 | BBTX | Bambusa Therapeutics, Inc. | 801.32M | -0.76% | 218,962 | - |
| 171 | ANNX | Annexon, Inc. | 796.23M | 4.87% | 2,622,006 | - |
| 172 | LXRX | Lexicon Pharmaceuticals, Inc. | 792.02M | 10.56% | 3,601,340 | 38.54M |
| 173 | ALMS | Alumis Inc. | 780.49M | 3.08% | 1,279,006 | 7.40M |
| 174 | DNA | Ginkgo Bioworks Holdings, Inc. | 760.27M | 13.35% | 3,039,013 | 130.75M |
| 175 | RIGL | Rigel Pharmaceuticals, Inc. | 746.61M | -13.26% | 759,188 | 288.21M |
| 176 | SLDB | Solid Biosciences Inc. | 735.51M | 6.63% | 1,426,524 | - |
| 177 | OABI | OmniAb, Inc. | 733.68M | 4.14% | 1,442,552 | 40.21M |
| 178 | CGEM | Cullinan Therapeutics, Inc. | 727.85M | 4.72% | 755,709 | - |
| 179 | ARDX | Ardelyx, Inc. | 723.95M | -3.68% | 5,452,590 | 468.22M |
| 180 | ABUS | Arbutus Biopharma Corporation | 723.13M | -0.41% | 1,717,965 | 181.72M |
| 181 | NVCT | Nuvectis Pharma, Inc. | 719.07M | 17.74% | 258,702 | - |
| 182 | SANA | Sana Biotechnology, Inc. | 709.48M | 1.28% | 2,305,390 | - |
| 183 | SGMT | Sagimet Biosciences Inc. | 698.45M | 8.00% | 857,927 | - |
| 184 | ATTO | Attovia Therapeutics, Inc. | 697.09M | 1.80% | 218,754 | 1.80M |
| 185 | ACHV | Achieve Life Sciences, Inc. | 691.50M | 5.33% | 1,075,731 | - |
| 186 | ZVRA | Zevra Therapeutics, Inc. | 689.66M | 10.07% | 1,534,643 | 147.76M |
| 187 | AURA | Aura Biosciences, Inc. | 680.30M | 3.47% | 859,023 | - |
| 188 | FDMT | 4D Molecular Therapeutics, Inc. | 676.74M | 8.89% | 993,257 | 92.01M |
| 189 | AVBP | ArriVent BioPharma, Inc. | 672.56M | 11.53% | 1,400,550 | - |
| 190 | CADL | Candel Therapeutics, Inc. | 669.54M | 8.83% | 955,020 | - |
| 191 | IMMX | Immix Biopharma, Inc. | 668.20M | 11.94% | 1,444,883 | - |
| 192 | WVE | Wave Life Sciences, Inc. | 663.68M | 4.50% | 2,205,149 | 70.92M |
| 193 | ANL | Adlai Nortye Group Ltd. | 662.01M | 6.20% | 531,007 | 18.06M |
| 194 | HELP | Helus Pharma Inc. | 654.62M | 6.79% | 1,210,025 | - |
| 195 | DSGN | Design Therapeutics, Inc. | 653.81M | 5.58% | 330,605 | - |
| 196 | KURA | Kura Oncology, Inc. | 646.74M | 6.91% | 3,087,653 | 77.23M |
| 197 | OLMA | Olema Pharmaceuticals, Inc. | 641.36M | 8.43% | 1,337,270 | - |
| 198 | GERN | Geron Corporation | 637.67M | 4.18% | 13,652,175 | 217.52M |
| 199 | DBVT | DBV Technologies S.A. | 628.83M | 6.63% | 210,654 | 3.74M |
| 200 | APMD | Apnimed, Inc. | 628.62M | 6.64% | 225,365 | 115.12M |
| 201 | ACRS | Aclaris Therapeutics, Inc. | 604.44M | 8.03% | 3,526,327 | 6.40M |
| 202 | CLYM | Climb Bio, Inc. | 591.02M | 16.01% | 1,140,063 | - |
| 203 | CBIO | Crescent Biopharma, Inc. | 579.53M | 4.64% | 137,774 | 11.88M |
| 204 | BCAX | Bicara Therapeutics Inc. | 572.40M | 5.62% | 1,010,560 | - |
| 205 | FTH | Faeth Therapeutics, Inc. | 569.78M | 10.69% | 539,427 | - |
| 206 | OVID | Ovid Therapeutics Inc. | 556.60M | 10.47% | 3,897,580 | 1.58M |
| 207 | ENTX | Entera Bio Ltd. | 546.12M | 5.02% | 118,328 | 42.00K |
| 208 | SRZN | Surrozen, Inc. | 542.35M | 6.90% | 140,729 | 11.51M |
| 209 | SLBT | SL Science Holding Limited | 534.62M | 4.16% | 53,778 | 3.27M |
| 210 | VALN | Valneva SE | 530.74M | -2.30% | 7,960 | 163.30M |
| 211 | CAPR | Capricor Therapeutics, Inc. | 523.25M | 4.65% | 4,664,303 | 11.13M |
| 212 | GYRE | Gyre Therapeutics, Inc. | 520.99M | 18.70% | 359,716 | 110.06M |
| 213 | INDP | Indaptus Therapeutics, Inc. | 509.89M | 5.06% | 274,520 | - |
| 214 | NGNE | Neurogene Inc. | 506.49M | -1.33% | 324,165 | 925.00K |
| 215 | DMAC | DiaMedica Therapeutics Inc. | 504.74M | 3.54% | 156,754 | - |
| 216 | RGNX | REGENXBIO Inc. | 503.85M | 3.25% | 1,186,483 | 153.91M |
| 217 | ETRA | Electra Therapeutics, Inc. | 489.58M | 6.12% | 401,302 | - |
| 218 | MDXG | MiMedx Group, Inc. | 483.01M | 0.91% | 1,106,856 | 303.73M |
| 219 | IAM | Iambic Therapeutics, Inc. | 482.07M | -12.63% | 672,498 | 18.25M |
| 220 | MNPR | Monopar Therapeutics Inc. | 479.38M | 6.25% | 94,209 | - |
| 221 | CTMX | CytomX Therapeutics, Inc. | 477.20M | 2.34% | 2,727,240 | 14.03M |
| 222 | STTK | Shattuck Labs, Inc. | 463.68M | 2.90% | 1,148,335 | 1.00M |
| 223 | OCS | Oculis Holding AG | 462.37M | 9.66% | 404,086 | 1.12M |
| 224 | EPRX | Eupraxia Pharmaceuticals Inc. | 453.94M | 4.39% | 585,090 | - |
| 225 | OBIO | Orchestra BioMed Holdings, Inc. | 434.26M | 1.07% | 1,741,382 | 31.98M |
| 226 | BLSM | BlossomHill Therapeutics, Inc. | 429.10M | 9.31% | 174,332 | - |
| 227 | PBYI | Puma Biotechnology, Inc. | 425.87M | -15.56% | 1,279,882 | 231.87M |
| 228 | YDES | YD Bio Limited | 422.86M | -16.85% | 207,609 | 1.24M |
| 229 | ARVN | Arvinas, Inc. | 419.76M | -2.14% | 1,212,726 | 275.30M |
| 230 | PHAT | Phathom Pharmaceuticals, Inc. | 417.01M | 3.35% | 1,770,849 | 274.88M |
| 231 | RLMD | Relmada Therapeutics, Inc. | 416.01M | 3.45% | 1,055,411 | - |
| 232 | ASMB | Assembly Biosciences, Inc. | 415.76M | 2.10% | 249,358 | 74.85M |
| 233 | CRMD | CorMedix Inc. | 414.66M | 1.72% | 1,616,987 | 462.25M |
| 234 | PRTA | Prothena Corporation plc | 409.16M | 1.01% | 421,782 | 52.74M |
| 235 | RZLT | Rezolute, Inc. | 407.00M | 6.59% | 1,520,531 | - |
| 236 | DTIL | Precision BioSciences, Inc. | 404.61M | 7.40% | 1,229,157 | 45.04M |
| 237 | ALT | Altimmune, Inc. | 404.60M | 5.58% | 2,773,868 | 31.00K |
| 238 | TECX | Tectonic Therapeutic, Inc. | 403.50M | 6.28% | 310,817 | - |
| 239 | AVTX | Avalo Therapeutics, Inc. | 400.71M | 4.52% | 1,112,295 | 59.00K |
| 240 | EDIT | Editas Medicine, Inc. | 394.70M | 0.78% | 1,716,919 | 47.01M |
| 241 | ZURA | Zura Bio Limited | 393.97M | 9.95% | 3,006,104 | - |
| 242 | MPLT | MapLight Therapeutics, Inc. | 385.14M | 11.41% | 501,985 | - |
| 243 | CCCC | C4 Therapeutics, Inc. | 381.38M | 5.08% | 4,325,794 | 32.28M |
| 244 | AGMB | AgomAb Therapeutics NV | 376.01M | 9.54% | 158,411 | - |
| 245 | CTNM | Contineum Therapeutics, Inc. | 373.81M | 8.06% | 343,536 | - |
| 246 | PRLD | Prelude Therapeutics Incorporated | 370.78M | 1.27% | 140,545 | 22.42M |
| 247 | LYEL | Lyell Immunopharma, Inc. | 365.34M | -0.93% | 250,936 | 15.00K |
| 248 | ASPE | Aspen Neuroscience, Inc. | 361.74M | 5.78% | 174,203 | - |
| 249 | ALLO | Allogene Therapeutics, Inc. | 359.31M | -4.59% | 12,625,093 | 4.64M |
| 250 | TRXB | TRex Bio, Inc. | 356.99M | 2.08% | 150,166 | - |
| 251 | IRD | Opus Genetics, Inc. | 347.76M | 4.37% | 784,742 | 9.86M |
| 252 | AVIR | Atea Pharmaceuticals, Inc. | 345.68M | 2.13% | 201,579 | - |
| 253 | PROK | ProKidney Corp. | 344.65M | 7.04% | 950,921 | 818.00K |
| 254 | FENC | Fennec Pharmaceuticals Inc. | 344.01M | 4.47% | 134,013 | 59.22M |
| 255 | AUTL | Autolus Therapeutics plc | 340.69M | 1.59% | 1,204,146 | 117.39M |
| 256 | ALEC | Alector, Inc. | 339.51M | 9.57% | 1,020,182 | 173.47M |
| 257 | BNTC | Benitec Biopharma Inc. | 332.78M | 10.42% | 120,361 | - |
| 258 | XFOR | X4 Pharmaceuticals, Inc. | 324.72M | 3.58% | 527,195 | 16.96M |
| 259 | AGEN | Agenus Inc. | 323.51M | 11.02% | 873,557 | 133.95M |
| 260 | ENTA | Enanta Pharmaceuticals, Inc. | 320.38M | 9.13% | 320,117 | 65.26M |
| 261 | EIKN | Eikon Therapeutics, Inc. | 319.57M | 1.03% | 402,387 | - |
| 262 | GALT | Galectin Therapeutics Inc. | 316.67M | 5.19% | 223,443 | - |
| 263 | OCGN | Ocugen, Inc. | 313.86M | 13.29% | 7,467,569 | 4.78M |
| 264 | IPSC | Century Therapeutics, Inc. | 304.21M | 11.26% | 1,896,547 | 109.16M |
| 265 | KYTX | Kyverna Therapeutics, Inc. | 301.80M | 5.86% | 885,569 | - |
| 266 | SCTX | Scribe Therapeutics Inc. | 297.23M | 1.42% | 324,462 | 33.30M |
| 267 | ARCT | Arcturus Therapeutics Holdings Inc. | 294.18M | 10.58% | 679,870 | 30.51M |
| 268 | VCRE | Vicore Pharma Holding AB (publ) | 291.21M | 3.90% | 12,244 | 383.48K |
| 269 | NAUT | Nautilus Biotechnology, Inc. | 284.04M | 3.72% | 4,554,281 | 424.00K |
| 270 | TTRX | Turn Therapeutics Inc. | 282.39M | 6.04% | 98,138 | - |
| 271 | FULC | Fulcrum Therapeutics, Inc. | 282.30M | 0.54% | 891,962 | 80.00M |
| 272 | SPRY | ARS Pharmaceuticals, Inc. | 280.47M | 5.28% | 5,673,081 | 122.14M |
| 273 | SABS | SAB Biotherapeutics, Inc. | 275.69M | 3.06% | 300,605 | 114.70K |
| 274 | QTTB | Q32 Bio Inc. | 275.37M | 4.52% | 214,763 | 53.74M |
| 275 | IKT | Inhibikase Therapeutics, Inc. | 273.11M | 4.17% | 356,019 | 1.00 |
| 276 | RCKT | Rocket Pharmaceuticals, Inc. | 261.81M | -2.05% | 1,425,861 | - |
| 277 | VTVT | vTv Therapeutics Inc. | 261.29M | -3.27% | 14,366 | 36.84M |
| 278 | CUVL | Clinuvel Pharmaceuticals Limited | 260.77M | 1.59% | 4,306 | 65.05M |
| 279 | VOGX | Vogenx, Inc. | 259.22M | -4.28% | 66,333 | - |
| 280 | LCTX | Lineage Cell Therapeutics, Inc. | 257.97M | 3.75% | 1,031,669 | 13.08M |
| 281 | CAMP | Camp4 Therapeutics Corporation | 254.78M | 9.14% | 128,682 | 5.32M |
| 282 | BCYC | Bicycle Therapeutics plc | 253.04M | 3.74% | 235,651 | 83.53M |
| 283 | LRMR | Larimar Therapeutics, Inc. | 249.48M | 3.02% | 973,640 | - |
| 284 | EVMN | Evommune, Inc. | 241.34M | 4.40% | 457,418 | 10.00M |
| 285 | ABEO | Abeona Therapeutics Inc. | 238.46M | 6.65% | 1,049,682 | 25.52M |
| 286 | IMRX | Immuneering Corporation | 238.33M | 9.20% | 681,548 | - |
| 287 | LXEO | Lexeo Therapeutics, Inc. | 237.10M | -0.52% | 1,007,036 | - |
| 288 | VNDA | Vanda Pharmaceuticals Inc. | 230.99M | 6.41% | 896,877 | 229.28M |
| 289 | RNAC | Cartesian Therapeutics, Inc. | 227.82M | 11.06% | 121,615 | 1.03M |
| 290 | GLSI | Greenwich LifeSciences, Inc. | 222.67M | 3.55% | 80,858 | - |
| 291 | ACIU | AC Immune SA | 221.72M | 5.69% | 180,407 | 23.75M |
| 292 | CABA | Cabaletta Bio, Inc. | 220.41M | 1.56% | 3,002,564 | - |
| 293 | FATE | Fate Therapeutics, Inc. | 219.87M | -0.81% | 1,862,248 | 4.75M |
| 294 | ELDN | Eledon Pharmaceuticals, Inc. | 211.89M | 5.89% | 621,289 | - |
| 295 | INO | Inovio Pharmaceuticals, Inc. | 205.25M | -16.21% | 39,724,657 | 65.34K |
| 296 | PLX | Protalix BioTherapeutics, Inc. | 204.65M | 1.20% | 364,044 | 80.62M |
| 297 | MDWD | MediWound Ltd. | 203.64M | 6.90% | 111,361 | 11.86M |
| 298 | ARTV | Artiva Biotherapeutics, Inc. | 202.89M | 0.48% | 908,723 | 251.00K |
| 299 | KRRO | Korro Bio, Inc. | 202.45M | 0.14% | 122,600 | 1.29M |
| 300 | SLGL | Sol-Gel Technologies Ltd. | 199.75M | -3.17% | 28,778 | 1.80M |
| 301 | PYXS | Pyxis Oncology, Inc. | 198.30M | 3.11% | 560,499 | 11.04M |
| 302 | PALI | Palisade Bio, Inc. | 196.93M | -2.59% | 2,032,623 | 500.00K |
| 303 | IFRX | InflaRx N.V. | 192.32M | -3.69% | 1,083,088 | -38.53K |
| 304 | PRQR | ProQR Therapeutics N.V. | 190.51M | 1.50% | 324,573 | 21.05M |
| 305 | CGEN | Compugen Ltd. | 185.66M | 2.08% | 183,989 | 74.00M |
| 306 | KROS | Keros Therapeutics, Inc. | 185.58M | -0.95% | 192,039 | 40.76M |
| 307 | DRUG | Bright Minds Biosciences Inc. | 183.29M | 11.11% | 197,379 | - |
| 308 | ACOG | Alpha Cognition Inc. | 180.54M | 1.72% | 114,393 | 15.26M |
| 309 | WHWK | Whitehawk Therapeutics, Inc. | 178.44M | 3.64% | 197,657 | 7.15M |
| 310 | UPB | Upstream Bio, Inc. | 176.91M | 0.62% | 1,139,878 | 3.16M |
| 311 | TRDA | Entrada Therapeutics, Inc. | 176.32M | 7.47% | 486,475 | 3.98M |
| 312 | PEPG | PepGen Inc. | 171.07M | 6.47% | 998,249 | - |
| 313 | IVVD | Invivyd, Inc. | 165.95M | -3.76% | 2,336,887 | 58.37M |
| 314 | CNTN | Canton Strategic Holdings, Inc. | 164.14M | 6.74% | 700,916 | 1.50M |
| 315 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 163.56M | -5.99% | 687,045 | - |
| 316 | ZNTL | Zentalis Pharmaceuticals, Inc. | 162.84M | 0.58% | 1,294,443 | 26.87M |
| 317 | ORMP | Oramed Pharmaceuticals Inc. | 160.57M | -0.77% | 112,539 | 2.00M |
| 318 | ALXO | ALX Oncology Holdings Inc. | 159.71M | 0.43% | 918,435 | - |
| 319 | STRO | Sutro Biopharma, Inc. | 159.51M | 4.57% | 182,655 | 45.70M |
| 320 | MSLE | Satellos Bioscience Inc. | 152.30M | 13.23% | 290,682 | - |
| 321 | ANTX | AN2 Therapeutics, Inc. | 150.94M | 1.14% | 240,355 | - |
| 322 | MGNX | MacroGenics, Inc. | 148.42M | 4.95% | 695,812 | 175.14M |
| 323 | SION | Sionna Therapeutics, Inc. | 148.30M | - | 986,937 | - |
| 324 | YARW | Yarrow Bioscience, Inc. | 145.15M | 14.71% | 229,756 | - |
| 325 | NGEN | NervGen Pharma Corp. | 143.01M | 0.76% | 447,779 | - |
| 326 | RNA | Atrium Therapeutics, Inc. | 142.66M | 0.24% | 108,191 | 35.84M |
| 327 | CMPX | Compass Therapeutics, Inc. | 136.65M | 10.84% | 1,850,030 | 850.00K |
| 328 | CUE | Cue Biopharma, Inc. | 136.06M | 4.00% | 205,562 | 37.66M |
| 329 | TARA | Protara Therapeutics, Inc. | 135.92M | 7.98% | 690,545 | - |
| 330 | VRXA | Veraxa Biotech AG | 134.34M | -0.23% | 222,357 | 29.54K |
| 331 | ADAG | Adagene Inc. | 134.29M | -0.99% | 189,026 | 9.29M |
| 332 | SPRB | Spruce Biosciences, Inc. | 133.79M | 8.99% | 63,699 | 697.00K |
| 333 | MENS | Jyong Biotech Ltd. | 133.62M | 9.09% | 38,788 | - |
| 334 | IPHA | Innate Pharma S.A. | 131.22M | 2.86% | - | 11.21M |
| 335 | ARMP | Armata Pharmaceuticals, Inc. | 130.51M | 17.00% | 69,314 | 5.54M |
| 336 | PYPD | PolyPid Ltd. | 124.71M | 8.29% | 185,613 | - |
| 337 | HUMA | Humacyte, Inc. | 124.51M | 13.32% | 5,158,004 | 2.12M |
| 338 | NKTX | Nkarta, Inc. | 123.91M | 10.19% | 2,106,515 | - |
| 339 | MOLN | Molecular Partners AG | 121.60M | -2.33% | 71 | 856.30K |
| 340 | CHRS | Coherus Oncology, Inc. | 118.97M | 2.82% | 1,082,264 | 50.94M |
| 341 | EQ | Equillium, Inc. | 118.33M | 13.53% | 218,504 | 4.39M |
| 342 | CDXS | Codexis, Inc. | 118.27M | 5.88% | 400,316 | 77.68M |
| 343 | ENGN | enGene Therapeutics Inc. | 117.28M | 4.17% | 1,426,918 | - |
| 344 | OKUR | OnKure Therapeutics, Inc. | 116.04M | 13.47% | 555,818 | - |
| 345 | NERV | Minerva Neurosciences, Inc. | 115.55M | 5.22% | 238,042 | - |
| 346 | VYGR | Voyager Therapeutics, Inc. | 114.92M | 8.43% | 870,781 | 25.11M |
| 347 | FHTX | Foghorn Therapeutics Inc. | 111.05M | -1.84% | 970,037 | 36.74M |
| 348 | ANIX | Anixa Biosciences, Inc. | 110.38M | 4.79% | 121,663 | - |
| 349 | LENZ | LENZ Therapeutics, Inc. | 109.97M | 16.28% | 785,555 | 12.36M |
| 350 | MIST | Milestone Pharmaceuticals Inc. | 107.49M | 10.15% | 556,417 | 2.34M |
| 351 | AVXL | Anavex Life Sciences Corp. | 106.60M | 3.60% | 1,054,020 | - |
| 352 | OTLK | Outlook Therapeutics, Inc. | 106.24M | -0.61% | 1,636,434 | -1.16M |
| 353 | IMUX | Immunic, Inc. | 105.74M | 5.87% | 179,741 | - |
| 354 | NBP | NovaBridge Biosciences | 105.50M | 0.15% | 418,738 | - |
| 355 | HURA | TuHURA Biosciences, Inc. | 103.87M | 1.24% | 403,070 | - |
| 356 | NRXP | NRx Pharmaceuticals, Inc. | 102.97M | 4.85% | 604,422 | 3.39M |
| 357 | BDTX | Black Diamond Therapeutics, Inc. | 99.68M | 4.52% | 432,114 | 70.00M |
| 358 | UNCY | Unicycive Therapeutics, Inc. | 98.89M | 2.01% | 603,427 | - |
| 359 | KZIA | Kazia Therapeutics Limited | 98.39M | 2.57% | 155,356 | 1.27M |
| 360 | TENX | Tenax Therapeutics, Inc. | 96.81M | 3.68% | 789,278 | - |
| 361 | VANI | Vivani Medical, Inc. | 96.52M | 2.88% | 262,559 | - |
| 362 | PMVP | PMV Pharmaceuticals, Inc. | 95.15M | -1.18% | 194,316 | - |
| 363 | NMRA | Neumora Therapeutics, Inc. | 94.57M | 3.35% | 984,207 | - |
| 364 | RTSN | Retension Pharmaceuticals, Inc. | 91.98M | 2.99% | 29,423 | - |
| 365 | SEER | Seer, Inc. | 90.26M | - | 198,464 | 14.22M |
| 366 | CBUS | Cibus, Inc. | 90.19M | 3.51% | 163,313 | 4.35M |
| 367 | PLYX | Polaryx Therapeutics, Inc. | 89.72M | 3.45% | 23,545 | - |
| 368 | PDSB | PDS Biotechnology Corporation | 89.14M | 5.13% | 2,946,857 | - |
| 369 | ICCC | ImmuCell Corporation | 89.01M | -1.51% | 8,243 | 30.68M |
| 370 | TLSA | Tiziana Life Sciences Ltd | 88.19M | 11.03% | 333,627 | - |
| 371 | TVGN | Tevogen Inc. | 87.97M | 0.54% | 37,191 | - |
| 372 | GNLX | Genelux Corporation | 87.83M | 7.69% | 323,773 | 8.00K |
| 373 | NTHI | NeOnc Technologies Holdings, Inc. | 86.75M | 9.06% | 228,026 | 39.99K |
| 374 | RLYB | Rallybio Corporation | 84.80M | 0.38% | 59,284 | 434.00K |
| 375 | CLLS | Cellectis S.A. | 81.46M | 3.88% | 27,721 | 63.82M |
| 376 | TNXP | Tonix Pharmaceuticals Holding Corp. | 81.30M | 3.04% | 741,820 | 29.10M |
| 377 | TNYA | Tenaya Therapeutics, Inc. | 80.77M | 13.99% | 2,909,918 | 3.03M |
| 378 | ATRA | Atara Biotherapeutics, Inc. | 79.00M | -1.13% | 16,300 | 6.19M |
| 379 | NRXS | NeurAxis, Inc. | 78.36M | 2.13% | 181,856 | 5.32M |
| 380 | RANI | Rani Therapeutics Holdings, Inc. | 76.22M | 5.93% | 462,617 | 4.88M |
| 381 | OKYO | OKYO Pharma Limited | 75.05M | 2.14% | 93,895 | - |
| 382 | MNOV | MediciNova, Inc. | 71.86M | 0.69% | 14,345 | 920.48K |
| 383 | COYA | Coya Therapeutics, Inc. | 70.14M | 6.41% | 230,566 | 8.02M |
| 384 | CNXU | Conexeu Sciences Inc. | 69.68M | 6.60% | 133,177 | - |
| 385 | ACRV | Acrivon Therapeutics, Inc. | 68.99M | 2.55% | 364,526 | - |
| 386 | NTRB | Nutriband Inc. | 67.46M | -0.54% | 13,347 | 1.62M |
| 387 | CSBR | Champions Oncology, Inc. | 66.67M | 0.63% | 4,254 | 60.66M |
| 388 | CGTX | Cognition Therapeutics, Inc. | 65.33M | 8.12% | 282,749 | - |
| 389 | MAIA | MAIA Biotechnology, Inc. | 64.48M | 1.92% | 249,318 | - |
| 390 | NORD | Nordicus Partners Corporation | 62.70M | -1.08% | 2,297 | - |
| 391 | CING | Cingulate Inc. | 61.95M | 0.47% | 104,087 | - |
| 392 | CRDF | Cardiff Oncology, Inc. | 61.87M | 5.30% | 349,377 | 508.00K |
| 393 | FBIO | Fortress Biotech, Inc. | 61.70M | 0.54% | 129,816 | 68.47M |
| 394 | SPRO | Spero Therapeutics, Inc. | 59.98M | 0.98% | 186,809 | 47.00M |
| 395 | GOSS | Gossamer Bio, Inc. | 59.76M | 3.72% | 84,733 | 53.29M |
| 396 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 59.38M | 7.34% | 685,226 | - |
| 397 | XBIT | XBiotech Inc. | 57.62M | 1.07% | 25,248 | - |
| 398 | KLRS | Kalaris Therapeutics, Inc. | 57.61M | 2.54% | 200,998 | - |
| 399 | XLO | Xilio Therapeutics, Inc. | 56.72M | 1.41% | 6,776 | 64.09M |
| 400 | CLNN | Clene Inc. | 56.15M | -0.50% | 60,759 | 238.00K |
| 401 | ONCY | Oncolytics Biotech Inc. | 56.03M | -2.09% | 516,951 | - |
| 402 | BOLD | Boundless Bio, Inc. | 55.96M | 2.07% | 94,045 | - |
| 403 | HRTX | Heron Therapeutics, Inc. | 55.63M | 4.64% | 1,165,503 | 151.18M |
| 404 | ALPS | Alps Group Inc | 54.86M | 4.90% | 460,465 | 3.74M |
| 405 | VRCA | Verrica Pharmaceuticals Inc. | 54.80M | 3.24% | 190,682 | 30.32M |
| 406 | RNTX | Rein Therapeutics Inc. | 52.94M | 0.28% | 409,341 | - |
| 407 | INKT | MiNK Therapeutics, Inc. | 52.82M | 2.99% | 7,674 | - |
| 408 | TELO | Telomir Pharmaceuticals, Inc. | 52.28M | -8.97% | 154,887 | - |
| 409 | RNXT | RenovoRx, Inc. | 51.00M | -5.04% | 1,845,285 | 2.78M |
| 410 | ELOX | Eloxx Pharmaceuticals, Inc. | 50.21M | -2.81% | 15,861 | - |
| 411 | PLRX | Pliant Therapeutics, Inc. | 50.14M | -0.75% | 151,615 | - |
| 412 | HYFT | MindWalk Holdings Corp. | 49.94M | 6.00% | 181,799 | 11.57M |
| 413 | HOWL | Werewolf Therapeutics, Inc. | 49.09M | -0.98% | 176,555 | 21.00M |
| 414 | CRBU | Caribou Biosciences, Inc. | 48.10M | 8.83% | 1,702,307 | 9.44M |
| 415 | IBIO | iBio, Inc. | 47.50M | 1.16% | 291,360 | 100.00K |
| 416 | IMA | ImageneBio, Inc. | 46.60M | -1.44% | 1,402 | 800.00K |
| 417 | TIL | Instil Bio, Inc. | 46.32M | -2.29% | 107,046 | - |
| 418 | OSTX | OS Therapies Incorporated | 46.21M | 2.03% | 984,758 | - |
| 419 | CNTB | Connect Biopharma Holdings Limited | 45.89M | -0.41% | 338,794 | 2.95M |
| 420 | MREO | Mereo BioPharma Group plc | 45.19M | 0.93% | 655,624 | 500.00K |
| 421 | ATNM | Actinium Pharmaceuticals, Inc. | 44.96M | 10.00% | 89,253 | 35.09M |
| 422 | GANX | Gain Therapeutics, Inc. | 44.95M | 7.25% | 328,332 | - |
| 423 | DWTX | Dogwood Therapeutics, Inc. | 43.51M | 23.08% | 173,994 | 100.00K |
| 424 | ATHE | Alterity Therapeutics Limited | 41.75M | 9.46% | 13,387 | 2.50M |
| 425 | APLM | Apollomics, Inc. | 41.72M | 11.90% | 14,046 | 413.00K |
| 426 | LONA | LeonaBio, Inc. | 41.60M | 1.73% | 50,012 | - |
| 427 | BMEA | Biomea Fusion, Inc. | 41.08M | -3.51% | 1,778,855 | - |
| 428 | EXOZ | eXoZymes, Inc. | 40.84M | 7.06% | 10,804 | -700.00 |
| 429 | ELTX | Elicio Therapeutics, Inc. | 39.69M | 7.86% | 756,123 | - |
| 430 | GRCE | Grace Therapeutics, Inc. | 38.92M | 3.93% | 114,873 | - |
| 431 | HYPD | Hyperion DeFi, Inc. | 38.69M | -2.73% | 429,526 | 1.40M |
| 432 | ALDX | Aldeyra Therapeutics, Inc. | 38.23M | 2.89% | 547,163 | - |
| 433 | PMN | ProMIS Neurosciences, Inc. | 37.31M | 13.97% | 376,158 | - |
| 434 | VERU | Veru Inc. | 36.15M | 2.91% | 137,145 | 16.89M |
| 435 | ANVS | Annovis Bio, Inc. | 36.00M | 26.31% | 11,735,883 | - |
| 436 | PTHS | Pelthos Therapeutics Inc. | 35.83M | 0.65% | 15,709 | 43.30M |
| 437 | SER | Serina Therapeutics, Inc. | 35.05M | -16.36% | 491,941 | 130.00K |
| 438 | IBO | Impact BioMedical Inc. | 35.03M | -6.82% | - | 35.00K |
| 439 | GRDX | GridAI Technologies Corp. | 34.84M | 5.35% | 67,060 | - |
| 440 | INMB | INmune Bio Inc. | 34.75M | -3.83% | 677,056 | 50.00K |
| 441 | BCTX | BriaCell Therapeutics Corp. | 34.50M | 20.80% | 160,528 | - |
| 442 | NNVC | NanoViricides, Inc. | 33.69M | 2.33% | 121,384 | - |
| 443 | ACET | Adicet Bio, Inc. | 32.83M | 4.45% | 254,061 | - |
| 444 | IRLA | IRulya Therapeutics Inc. | 31.53M | 5.77% | 33,548 | - |
| 445 | EYPT | EyePoint, Inc. | 31.04M | 1.15% | 5,980,174 | 2.79M |
| 446 | LITS | Lite Strategy, Inc. | 31.02M | 4.93% | 233,233 | - |
| 447 | EDSA | Edesa Biotech, Inc. | 28.91M | 0.47% | 37,766 | - |
| 448 | PLRZ | Polyrizon Ltd. | 26.82M | -4.70% | 8,033 | - |
| 449 | MGX | Metagenomi Therapeutics, Inc. | 26.80M | -2.93% | 350,655 | 13.56M |
| 450 | BYSI | BeyondSpring Inc. | 25.74M | -1.01% | 34,908 | 1.88M |
| 451 | AARD | Aardvark Therapeutics, Inc. | 25.61M | 5.41% | 221,840 | - |
| 452 | CVM | CEL-SCI Corporation | 25.50M | 5.84% | 46,675 | - |
| 453 | ALGS | Aligos Therapeutics, Inc. | 25.42M | -9.76% | 101,672 | 33.65M |
| 454 | RNAZ | TransCode Therapeutics, Inc. | 25.23M | -1.32% | 12,793 | - |
| 455 | ABVC | ABVC BioPharma, Inc. | 25.15M | -0.25% | 20,528 | 797.92K |
| 456 | EVAX | Evaxion A/S | 25.02M | 8.70% | 184,241 | 7.49M |
| 457 | CELU | Celularity Inc. | 24.67M | 4.80% | 60,564 | 18.67M |
| 458 | NXTC | NextCure, Inc. | 24.40M | 4.10% | 49,878 | - |
| 459 | FLNA | Filana Therapeutics, Inc. | 21.87M | 0.38% | 608,290 | - |
| 460 | CRVO | CervoMed Inc. | 21.47M | -2.07% | 587,078 | 8.73K |
| 461 | IMMP | Immutep Limited | 21.28M | 24.16% | 97,169 | 13.79M |
| 462 | ATOS | Atossa Therapeutics, Inc. | 21.16M | 4.95% | 34,833 | - |
| 463 | BSEM | BioStem Technologies, Inc. | 21.00M | 8.65% | 100,819 | 34.59M |
| 464 | IGC | IGC Pharma, Inc. | 20.68M | 5.82% | 615,170 | 1.11M |
| 465 | COCP | Cocrystal Pharma, Inc. | 20.03M | 4.00% | 26,564 | 330.00K |
| 466 | MCRB | Seres Therapeutics, Inc. | 19.89M | -5.26% | 82,279 | 2.13M |
| 467 | KTTA | Pasithea Therapeutics Corp. | 19.34M | 11.31% | 436,906 | - |
| 468 | JSPR | Jasper Therapeutics, Inc. | 18.70M | 19.74% | 63,650 | - |
| 469 | ACTU | Actuate Therapeutics, Inc. | 18.08M | 0.55% | 518,073 | - |
| 470 | BIVI | BioVie Inc. | 17.91M | 9.92% | 184,386 | - |
| 471 | QNTM | Quantum BioPharma Ltd. | 17.83M | -0.24% | 43,625 | - |
| 472 | CNTX | Context Therapeutics Inc. | 17.78M | 2.98% | 1,313,745 | - |
| 473 | QNRX | Quoin Pharmaceuticals, Ltd. | 17.54M | -5.19% | 25,607 | - |
| 474 | BOLT | Bolt Biotherapeutics, Inc. | 16.91M | 2.51% | 136,537 | 4.70M |
| 475 | AKTX | Akari Therapeutics, Plc | 16.84M | -4.90% | 53,062 | - |
| 476 | ESLA | Estrella Immunopharma, Inc. | 16.32M | -8.49% | 140,928 | - |
| 477 | ABOS | Acumen Pharmaceuticals, Inc. | 16.17M | 4.54% | 2,005,856 | - |
| 478 | NCEL | NewcelX Ltd. | 15.74M | -5.73% | 11,240 | - |
| 479 | ATYR | aTyr Pharma, Inc. | 15.57M | 5.31% | 70,084 | 190.00K |
| 480 | ALLR | Allarity Therapeutics, Inc. | 15.35M | -1.13% | 64,307 | 345.00K |
| 481 | PLUR | Pluri Inc. | 15.25M | 3.81% | 4,750 | 1.02M |
| 482 | KYNB | Kyntra Bio, Inc. | 15.10M | 1.91% | 14,597 | 4.62M |
| 483 | NEUP | Neuphoria Therapeutics Inc. | 15.04M | 0.36% | 19,631 | 1.17M |
| 484 | CTXR | Citius Pharmaceuticals, Inc. | 14.96M | -2.21% | 199,831 | 7.11M |
| 485 | MRKR | Marker Therapeutics, Inc. | 14.89M | -0.30% | 50,360 | 3.55M |
| 486 | LPCN | Lipocine Inc. | 12.94M | 2.61% | 509,749 | 3.74M |
| 487 | BCDA | BioCardia, Inc. | 12.87M | -4.49% | 167,680 | 3.00K |
| 488 | PASG | Passage Bio, Inc. | 12.79M | 14.88% | 22,039 | - |
| 489 | TVRD | Tvardi Therapeutics, Inc. | 12.78M | 10.79% | 55,774 | - |
| 490 | TCRX | TScan Therapeutics, Inc. | 12.74M | 3.41% | 279,414 | 7.11M |
| 491 | DARE | Daré Bioscience, Inc. | 12.57M | 2.40% | 53,087 | 1.37M |
| 492 | DYAI | Dyadic International, Inc. | 12.38M | -0.09% | 67,026 | 3.80M |
| 493 | GUTS | Fractyl Health, Inc. | 12.33M | 3.80% | 85,572 | 3.00K |
| 494 | RADX | Radiopharm Theranostics Limited | 11.93M | 7.85% | 79,242 | 8.90M |
| 495 | CLRB | Cellectar Biosciences, Inc. | 11.82M | 8.70% | 76,953 | - |
| 496 | PBM | Psyence Biomedical Ltd. | 11.29M | 0.68% | 24,525 | - |
| 497 | HIND | Vyome Holdings, Inc. | 11.09M | -3.07% | 19,781 | 129.73K |
| 498 | AZR | Azora Therapeutics, Inc. | 10.50M | 7.82% | 78,187 | - |
| 499 | PPBT | Purple Biotech Ltd | 10.49M | 4.80% | 42,465 | - |
| 500 | PTN | Palatin Technologies, Inc. | 10.40M | 9.81% | 33,993 | 13.19M |